Phase III trial of concurrent thoracic radiotherapy (TRT) with either the first cycle or the third cycle of cisplatin and etoposide chemotherapy to determine the optimal …
K Park, JM Sun, SW Kim, M Ahn, JS Ahn, DH Lee… - 2012 - ascopubs.org
7004 Background: Concurrent thoracic radiotherapy (TRT) with chemotherapy has been
regarded as optimal treatment for limited-disease small cell lung cancer (SCLC). However …
regarded as optimal treatment for limited-disease small cell lung cancer (SCLC). However …
[HTML][HTML] Phase III trial of concurrent thoracic radiotherapy with either first-or third-cycle chemotherapy for limited-disease small-cell lung cancer
Background We compared late thoracic radiotherapy (TRT) with early TRT in the treatment
of limited-disease small-cell lung cancer (LD-SCLC). Patients and methods Patients with LD …
of limited-disease small-cell lung cancer (LD-SCLC). Patients and methods Patients with LD …
Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined‐modality treatment of limited‐stage …
SS Kamath, DL McCarley… - Radiation Oncology …, 1998 - Wiley Online Library
In an attempt to verify the relative efficacy of early concurrent vs. sequential timing of thoracic
radiotherapy (TRT) and platinum/etoposide chemotherapy, 48 patients with limited‐stage …
radiotherapy (TRT) and platinum/etoposide chemotherapy, 48 patients with limited‐stage …
Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter …
SG Spiro, LE James, RM Rudd, CW Trask… - Journal of clinical …, 2006 - ascopubs.org
Purpose To replicate an earlier National Cancer Institute of Canada (NCIC) trial that
examined the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with …
examined the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with …
Mid-course thoracic radiotherapy with cisplatin-etoposide chemotherapy in limited-stage small-cell lung cancer
S Akyurek, C Onal, A Cagar, A Hicsonmez… - Medical Oncology, 2006 - Springer
Combination chemoradiotherapy is a standard treatment for limited-stage small-cell lung
cancer (LS-SCLC). However, there is still controversery about the optimal timing of thoracic …
cancer (LS-SCLC). However, there is still controversery about the optimal timing of thoracic …
Timing of thoracic radiation therapy with chemotherapy in limited-stage small-cell lung cancer: survey of US radiation oncologists on current practice patterns
MJ Farrell, JB Yahya, C Degnin, Y Chen, JM Holland… - Clinical Lung Cancer, 2018 - Elsevier
Introduction For limited-stage small-cell lung cancer (LS-SCLC), National Comprehensive
Cancer Network guidelines recommend that thoracic radiotherapy (TRT) be delivered …
Cancer Network guidelines recommend that thoracic radiotherapy (TRT) be delivered …
[HTML][HTML] Duration of twice-daily thoracic radiotherapy and time from the start of any treatment to the end of chest irradiation as significant predictors of outcomes in …
M Morimoto, K Okishio, M Akira, N Omachi, A Tamiya… - Clinical Lung Cancer, 2017 - Elsevier
Background The hypothesis of this retrospective study was that the duration of twice-daily
(BID) thoracic radiotherapy (TRT) and time from the start of any treatment to the end of chest …
(BID) thoracic radiotherapy (TRT) and time from the start of any treatment to the end of chest …
[HTML][HTML] Is there a place for optimizing thoracic radiotherapy in limited-stage small cell lung cancer after twenty years?
JM Barros, MM Rizzo, JO Chiozza… - World Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Thoracic radiotherapy (TRT) is one of the main treatments in limited-stage small cell lung
cancer (LS-SCLC). Hyperfractionated TRT (45 Gy, 1.5 Gy twice daily) has been the standard …
cancer (LS-SCLC). Hyperfractionated TRT (45 Gy, 1.5 Gy twice daily) has been the standard …
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical …
N Murray, P Coy, JL Pater, I Hodson… - Journal of Clinical …, 1993 - ascopubs.org
PURPOSE The importance of the timing of thoracic irradiation (TI) in the combined modality
therapy of limited-stage small-cell lung cancer (SCLC) was assessed in a randomized trial …
therapy of limited-stage small-cell lung cancer (SCLC) was assessed in a randomized trial …
Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer
BH Grønberg, TO Halvorsen, Ø Fløtten… - Acta …, 2016 - Taylor & Francis
Background: Concurrent chemotherapy and thoracic radiotherapy (TRT) is recommended
for limited disease small cell lung cancer (LD SCLC). Twice daily TRT is well documented …
for limited disease small cell lung cancer (LD SCLC). Twice daily TRT is well documented …